Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Shalabh Gupta

Shalabh Gupta is recorded as CEO and Board Member at Unicycive Therapeutics, Inc. (UNCY). The proxy statement of Unicycive Therapeutics, Inc. reports total compensation of $2,439,884 for Shalabh Gupta in fiscal 2024, including a base salary of $572,000. Disclosed compensation is on record for 5 fiscal years.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Unicycive Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Unicycive Therapeutics, Inc. (UNCY) $572,000 $2,439,884
2023 Unicycive Therapeutics, Inc. (UNCY) $550,000 $4,044,062
2022 Unicycive Therapeutics, Inc. (UNCY) $550,000 $1,511,735
2021 Unicycive Therapeutics, Inc. (UNCY) $669,775 $1,124,691
2020 Unicycive Therapeutics, Inc. (UNCY) $495,000 $643,500

Recent activity

No call appearances or filed executive changes recorded yet.